Height is correlated with circulating levels of insulin-like growth factor (IGF)-I, the main mediator of growth hormone activity and a hormone that has been positively associated with cancers at a number of anatomic sites [31–35], but IGF-1 levels are generally inversely related with circulatory disease risk [36–40]. Here, GH1 is linked to cancer.